The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Iuliia Burmistrova/Getty Images The FDA has ordered compounding pharmacies to stop making less expensive versions of popular weight loss medications like Ozempic and Zepbound. The order comes ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 ...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 billion in four new manufacturing sites in the United States. But the ...

These branded prescription pharmaceuticals – approved by the Food and Drug Administration – are so popular and in demand that pharmaceutical manufacturers could not keep up with production.

Zepbound (tirzepatide) is a prescription drug used to help with weight loss and sleep apnea in certain ... for OSA is the same as shown in this chart, except that the typical maintenance dosage ...

Eli Lilly has emerged as a popular growth stock thanks to its strength in the weight loss space ... Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

Despite instructions of closure by federal authorities tomorrow, many compounded versions of weight-loss drugs are available ...